Monokine with inflammatory and chemokinetic properties binds to CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant MIP-1-beta induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). The processed form MIP-1-beta (3-69) retains the abilities to induce down-modulation of surface expression of the chemokine receptor CCR5 and to inhibit the CCR5-mediated entry of HIV-1 in T-cells. MIP-1-beta(3-69) is also a ligand for CCR1 and CCR2 isoform B.
6.72 Scientific score
Choose a variant
|Catalog ID||CCL4-1mg||Supplier Catalog ID||CCL4-1mg|
|Size||1 mg||Price||$ 1,381.25|
|Supplier||ChemoTactics, Inc.||Package Content||CCL4 (MIP-1β) Chemokine, 1 mg|
|Purity||> 97 %||Molecular Weight||7.818 kDa|
|Solubility||Sterile water||Shipping Condition||Room temperature|
|Shipping Temperature||20 °C||Storage & Handling||-20 °C|
|Shelf Life||12 months||Research Topics||/|
For research use only.